Cargando…
Patient-Derived Extracellular Vesicles Proteins as New Biomarkers in Multiple Myeloma - A Real-World Study
Multiple myeloma (MM) is a hematological malignancy of clonal antibody–secreting plasma cells (PCs). MM diagnosis and risk stratification rely on bone marrow (BM) biopsy, an invasive procedure prone to sample bias. Liquid biopsies, such as extracellular vesicles (EV) in peripheral blood (PB), hold p...
Autores principales: | Ferreira, Bruna Velosa, Carneiro, Emilie Arnault, Pestana, Carolina, Barahona, Filipa, Caetano, Joana, Lopes, Raquel, Lúcio, Paulo, Neves, Manuel, Beck, Hans Christian, Carvalho, Ana Sofia, Matthiesen, Rune, Costa-Silva, Bruno, João, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254863/ https://www.ncbi.nlm.nih.gov/pubmed/35800053 http://dx.doi.org/10.3389/fonc.2022.860849 |
Ejemplares similares
-
Multiple Myeloma-Derived Extracellular Vesicles Modulate the Bone Marrow Immune Microenvironment
por: Lopes, Raquel, et al.
Publicado: (2022) -
Boosting Immunity against Multiple Myeloma
por: Lopes, Raquel, et al.
Publicado: (2021) -
P841: EXTRACELLULAR VESICLE PROTEINS AS BIOMARKER OF OUTCOME IN MULTIPLE MYELOMA - A REAL-WORLD STUDY
por: Arnault Carneiro, E., et al.
Publicado: (2022) -
The Immune Microenvironment in Multiple Myeloma: Friend or Foe?
por: Lopes, Raquel, et al.
Publicado: (2021) -
P821: HIGH-DIMENSIONAL SPECTRAL CYTOMETRY CHARACTERIZATION OF THE CIRCULATING IMMUNE CELL PROFILE IN ASYMPTOMATIC AND SYMPTOMATIC MYELOMA PATIENTS.
por: Caetano, Joana, et al.
Publicado: (2023)